The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Merkel Cell Carcinoma - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Keratoconjunctivitis sicca (Dry Eye) - Pricing and Market Access provides country specific insights in order to estimate market potential for Keratoconjunctivitis sicca (Dry Eye) b...
November 2019
120 pages
Myelodysplastic Syndrome - Pipeline Review, 2019
US$ 1,250.00
Firstview Insight's Myelodysplastic Syndrome - Pipeline Review, 2019 provides an overview of the pipeline landscape of Myelodysplastic Syndrome It provides comprehensive insights of all the clinical a...
November 2019
150 pages
Non Small cell Lung cancer(NSCLC) - Pipeline Review, 2019
US$ 1,250.00
FirstView Market Insight ' Non Small cell Lung cancer(NSCLC)- Pipeline Review, 2019' provides an overview of the pipeline landscape. It provides comprehensive insights of all the clinical and non-clin...
November 2019
182 pages
Ulcerative colitis - Pipeline Review, 2019
US$ 1,250.00
FirstView Market Insight 'Ulcerative Colitis- Pipeline Review, 2019' provides an overview of the pipeline landscape for Ulcerative Colitis- Pipeline Review, 2019. It provides comprehensive insights of...
November 2019
146 pages
Hand, Foot and Mouth Disease Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
Hand, Foot and Mouth Disease Drug pipeline report- 2020 is an annual R&D review of Hand, Foot and Mouth Disease pipeline candidates. The report presents the current status of all major Hand, Foot and...
October 2019
40 pages
